R&D

Pipeline

Category Project Indication Discovery Pre-Clinical Phase Ⅰ
Efficacy Toxicity Ia Ib
Cancer
AGM-331
Targeted anti-cancer therapy
AGM-130
Treatment for Triple Negative Breast Cancer
Virus
Infection
AGM-380
Treatment for viral infection
Super
Bacteria
AGM-290
Treatment for infection caused by multidrug resistant bacteria
Metabolic
Disease
AGM-212
Treatment for Type 2 Diabetes
AGM-217
Treatment for Type 2 Diabetes and Obesity
Inflammatory
Bowel Disease
AGM-260
Treatment for Ulcerative colitis